Acute respiratory distress syndrome (ARDS) in premature infants is one of the leading causes of death. Surfactant replacement therapy has been the mainstay of treatment for preterm infants with RDS. This study aimed to evaluate the results of surfactant therapy for premature infants with RDS at the Pediatric Center of Hue Central Hospital. |